Completed NCT05735769

Anti-COVID-19 Vaccine Side Effects

Gender-dependent Symptoms Following Anti-COVID-19 Vaccine in a Lebanese and Italian Populations

Sponsor: Lebanese University

Conditions COVID-19 Vaccine Adverse Reaction Gender Vaccine Adverse Reaction

Updated 3 times since 2023 Last updated: Feb 20, 2023 Started: Jan 1, 2021 Primary completion: Jul 30, 2021 Completion: Sep 15, 2021

This observational or N/A phase trial investigates COVID-19 Vaccine Adverse Reaction and Gender and is currently completed. Lebanese University leads this study, which shows 3 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2023 — Jul 2024 [monthly]

Completed

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lebanese University
University of Bari

Data source: University of Bari

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bari, Italy